The broad healthcare sector accounts for roughly one-fifth of the U.S. economy and continues to expand. While most attention tends to go to the direct-care segment, the life-sciences industry is an ...
Lam Research (LRCX) surged +6.3% on 12/18/2025, propelled by a series of analyst price target upgrades. This surge was pronounced, with volume approximately 10% above the average, indicating more than ...
Zacks Investment Research on MSN
Implied volatility surging for Gilead Sciences stock options
Investors in Gilead Sciences, Inc. GILD need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 20, 2026 $150.00 Put had some of the highest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results